# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA650978 | Functional | Minimum inhibitory concentration required for antibacterial activity against Bacillus subtilis | Bacillus subtilis | 15 | ALA1127131 | organism-based format | Scientific Literature | |
2. | ALA679914 | Functional | Minimum inhibitory concentration required for antibacterial activity against Enterobacter | Enterobacter | 16 | ALA1127131 | organism-based format | Scientific Literature | |
3. | ALA676802 | Functional | Minimum inhibitory concentration required for antibacterial activity against Escherichia coli | Escherichia coli | 16 | ALA1127131 | organism-based format | Scientific Literature | |
4. | ALA702788 | Functional | Minimum inhibitory concentration required for antibacterial activity against Klebsiella | Klebsiella | 16 | ALA1127131 | organism-based format | Scientific Literature | |
5. | ALA880782 | Functional | Minimum inhibitory concentration required for antibacterial activity against Morganella | morganella | 14 | ALA1127131 | organism-based format | Scientific Literature | |
6. | ALA1614670 | ADME | Volume of distribution at steady state in human after iv administration | Homo sapiens | 667 | ALA1614632 | organism-based format | Scientific Literature | |
7. | ALA1614671 | ADME | Clearance in human after iv administration | Homo sapiens | 667 | ALA1614632 | organism-based format | Scientific Literature | |
8. | ALA1614672 | ADME | Fraction unbound in human after iv administration | Homo sapiens | 554 | ALA1614632 | organism-based format | Scientific Literature | |
9. | ALA1614673 | ADME | Mean residence time in human after iv administration | Homo sapiens | 667 | ALA1614632 | organism-based format | Scientific Literature | |
10. | ALA1614674 | ADME | Half life in human after iv administration | Homo sapiens | 667 | ALA1614632 | organism-based format | Scientific Literature | |
11. | ALA1614675 | ADME | Clearance in rat after iv administration | Rattus norvegicus | 103 | ALA1614629 | organism-based format | Scientific Literature | |
12. | ALA1614676 | ADME | Volume of distribution at steady state in rat after iv administration | Rattus norvegicus | 103 | ALA1614629 | organism-based format | Scientific Literature | |
13. | ALA1614677 | ADME | Clearance in dog after iv administration | Canis lupus familiaris | 103 | ALA1614629 | organism-based format | Scientific Literature | |
14. | ALA1614678 | ADME | Volume of distribution at steady state in dog after iv administration | Canis lupus familiaris | 103 | ALA1614629 | organism-based format | Scientific Literature | |
15. | ALA1614679 | ADME | Clearance in monkey after iv administration | Macaca | 103 | ALA1614629 | organism-based format | Scientific Literature | |
16. | ALA1614680 | ADME | Volume of distribution at steady state in monkey after iv administration | Macaca | 103 | ALA1614629 | organism-based format | Scientific Literature | |
17. | ALA1614681 | ADME | Clearance in human after iv administration | Homo sapiens | 103 | ALA1614629 | organism-based format | Scientific Literature | |
18. | ALA1614682 | ADME | Volume of distribution at steady state in human after iv administration | Homo sapiens | 103 | ALA1614629 | organism-based format | Scientific Literature | |
19. | ALA769331 | Functional | Minimum inhibitory concentration required for antibacterial activity against Providencia | Providencia | 16 | ALA1127131 | organism-based format | Scientific Literature | |
20. | ALA1035433 | ADME | Total body clearance in human | Homo sapiens | 390 | ALA1151930 | organism-based format | Scientific Literature |